Nedelea Dana-Georgiana, Vulpe Diana Elena, Gherghiceanu Florentina, Capitanu Bogdan Sorin, Dragosloveanu Serban, Stoica Ioan Cristian
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Department of Orthopedics, Foisor Clinical Hospital of Orthopedics, Traumatology and Osteoarticular Tuberculosis, Bucharest, Romania.
J Med Life. 2025 Mar;18(3):196-207. doi: 10.25122/jml-2025-0039.
Spondylolisthesis is a spinal condition characterized by the forward or backward displacement of a vertebral body, most commonly affecting the lower lumbar spine. It can be classified into different types, with isthmic and degenerative being the most prevalent. Early diagnosis is essential to initiate appropriate treatment based on symptom severity, degree of slippage, and neurological deficits. Non-surgical management is the first-line approach for low-grade spondylolisthesis (Grade I-II) and includes physical therapy, activity modification, pain management with nonsteroidal anti-inflammatory drugs or epidural steroid injections, and, in some cases, bracing. While most patients experience symptom relief with conservative treatment, those with progressive neurological deficits, severe pain, or significant instability may require surgery. Surgical options typically include decompression for nerve compression and fusion to stabilize the spine. The choice between decompression alone and decompression with fusion remains controversial, particularly in degenerative spondylolisthesis without initial instability. Posterior lumbar interbody fusion and transforaminal lumbar interbody fusion are the most performed techniques, with minimally invasive surgery gaining popularity due to its less aggressive impact on tissues and faster recovery. Long-term follow-up is necessary to monitor for complications such as adjacent segment disease, pseudarthrosis, or reoperation rate. Advances in imaging, surgical navigation, and regenerative medicine are important for the future of spondylolisthesis treatment, but current management remains centered on optimizing patient outcomes through individualized care and evidence-based treatment selection.
腰椎滑脱是一种脊柱疾病,其特征是椎体向前或向后移位,最常影响下腰椎。它可分为不同类型,其中峡部裂型和退变型最为常见。早期诊断对于根据症状严重程度、滑脱程度和神经功能缺损启动适当治疗至关重要。非手术治疗是低度腰椎滑脱(I-II级)的一线治疗方法,包括物理治疗、活动调整、使用非甾体抗炎药或硬膜外类固醇注射进行疼痛管理,在某些情况下还包括支具治疗。虽然大多数患者通过保守治疗症状会缓解,但那些有进行性神经功能缺损、严重疼痛或明显不稳定的患者可能需要手术。手术选择通常包括解除神经压迫的减压手术和稳定脊柱的融合手术。单纯减压手术和减压融合手术之间的选择仍存在争议,尤其是在没有初始不稳定的退变性腰椎滑脱中。后路腰椎椎间融合术和经椎间孔腰椎椎间融合术是最常用的技术,由于微创手术对组织的侵袭性较小且恢复较快,其越来越受欢迎。长期随访对于监测诸如相邻节段疾病、假关节形成或再次手术率等并发症是必要的。成像、手术导航和再生医学的进展对腰椎滑脱治疗的未来很重要,但目前的治疗仍以通过个体化护理和基于证据的治疗选择优化患者预后为中心。